2018
DOI: 10.3233/jrs-180745
|View full text |Cite
|
Sign up to set email alerts
|

Citizen petition: Sexual side effects of SSRIs and SNRIs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
18
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 26 publications
(18 citation statements)
references
References 48 publications
0
18
0
Order By: Relevance
“…The reduced sensitivity is accompanied by an immediate delay of ejaculation in men and muting of orgasm in both men and women. After a period of treatment, orgasm may stop and there may be a loss of libido (Healy et al ., 2018 a ).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The reduced sensitivity is accompanied by an immediate delay of ejaculation in men and muting of orgasm in both men and women. After a period of treatment, orgasm may stop and there may be a loss of libido (Healy et al ., 2018 a ).…”
Section: Introductionmentioning
confidence: 99%
“…At present PGAD appears to affect women more than men. This condition seems more likely to happen around the menopause, and while closely related to discontinuation from SSRI medication, can also occur following trauma to the genital area (Healy et al ., 2018 a ).…”
Section: Introductionmentioning
confidence: 99%
“…3,4 PSSD can persist for decades afterward. 2,5 In 2001, persistent genital arousal disorder (PGAD), an enduring disorder of irritable genital sensation, was described. 6 This condition is not linked to enhanced libido and does not stem from psychological issues.…”
mentioning
confidence: 99%
“…Immediately on taking a selective serotonin reuptake inhibitor (SSRI), most people have some genital anaesthesia 1. This may be aggravated on withdrawal of the drug and can remain for years after treatment has stopped, constituting post-SSRI sexual dysfunction (PSSD) 2.…”
mentioning
confidence: 99%
“…A standard refrain is that randomised clinical trials of short duration and small size have limited ability to detect rare effects of drugs, implying that longer trials are all that’s needed. But as indicated by the sexual effects of SSRIs, which are more common than their mood effects,1 a possibly greater problem lies not in whether we can detect rare adverse events but in our limited ability to detect common ones. Fetishising RCTs as medicine’s only true tool for establishing drug-effect relations may be one reason for this problem.…”
mentioning
confidence: 99%